Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 12:9:3081.
doi: 10.3389/fmicb.2018.03081. eCollection 2018.

Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?

Luana Rossato  1 , Arnaldo Lopes Colombo  1
Affiliations
Review

Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?

Luana Rossato et al. Front Microbiol. .

Abstract

Candida auris has emerged globally as a multidrug-resistant (MDR) medical care-associated fungal pathogen. Recent reports have demonstrated that C. auris usually expresses fewer virulence factors than does Candida albicans. However, the tendency of C. auris transmission within and between healthcare facilities is unique among Candida spp. and is possibly promoted by virulence and pathogenicity factors that facilitate skin colonization and environmental persistence. To understand the ability of this yeast to cause disease, we herein discuss several virulence and pathogenicity aspects of C. auris.

Keywords: Candida auris; biofilms; genomics; pathogenicity; phenotypic traits; thermic and osmotic stress; virulence.

PubMed Disclaimer

References

    1. Ben-Ami R., Berman J., Novikov A., Bash E., Shachor-Meyouhas Y., Zakin S., et al. (2017). Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerging Infectious Diseases. 23 195–203. 10.3201/eid2302.161486 - DOI - PMC - PubMed
    1. Borman A. M., Szekely A., Johnson E. M. (2016). Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species. mSphere. 1 e189–e116. 10.1128/mSphere.00189-16 - DOI - PMC - PubMed
    1. Calvo B., Melo A. S., Perozo-Mena A., Hernandez M., Francisco E. C., Hagen F., et al. (2016). First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 73 369–374. 10.1016/j.jinf.2016.07.008 - DOI - PubMed
    1. Cendejas-Bueno E., Kolecka A., Alastruey-Izquierdo A., Theelen B., Groenewald M., Kostrzewa M., et al. (2012). Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts. Journal of Clinical Microbiology. 50 3641–3651. 10.1128/JCM.02248-12 - DOI - PMC - PubMed
    1. Chatterjee S., Alampalli S. V., Nageshan R. K., Chettiar S. T., Joshi S., Tatu U. S. (2015). Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. 16:686. 10.1186/s12864-015-1863-z - DOI - PMC - PubMed